Evidence Hub

Percutaneous Right Ventricular Assist Device for Managing Decompensated Right Heart Failure in Pulmonary Arterial Hypertension

Kelley D, Abdelmonem A, Abdullah I, Makhumalo W, Ahari JE

Cureus, 2025

Abstract

Management of pulmonary arterial hypertension (PAH) with concomitant decompensated right-sided heart failure refractory to conventional pharmacotherapy presents a significant and multifaceted medical challenge. Although extracorporeal membrane oxygenation has been proven as an effective emergency intervention for unresponsive cardiopulmonary failure, the alternative use of a right ventricular assist device (RVAD) holds promise in the appropriate setting. We present a case of RVAD use in a patient with life-threatening acute PAH who was successfully bridged through critical decompensation to discharge without the need for more invasive procedures.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free